// App-Quantinova.ai

1205 : Real-World Remission Outcomes in the First Year Following RA Diagnosis Vary Considerably with the Disease Activity Index Used and a Sizable Proportion Have Persistent Active Disease Across All Measures: Results from the Canadian Early Arthritis Cohort (CATCH)

Researchers

Presenter

  • Susan J. Bartlett

Principal Investigators

  • Marie-France Valois

  • Louis Bessette

  • Gilles Boire

  • Glen Hazlewood

  • Carol Hitchon

  • Edward Keystone

  • Janet Pope

  • Carter Thorne

  • Diane Tin

  • Vivian Bykerk

Medical Centers

  • University of Toronto, Montreal, Canada

  • Montreal University, Montreal, QC, Canada

  • Montreal University, Montreal, QC, Canada

  • Laval University, Quebec, Quebec, Canada.

  • Sherbrooke University, Sherbrooke, Quebec, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Western Univeristy, London, ON, Canada

  • Stronach Regional Cancer Centre, Newmarket, ON, Canada

  • Southlake Regional Health Center, Newmarket, Ontario, Canada

  • Hospital for Special Surgery, New York, NY.

  • Canadian Early Arthritis Cohort (CATCH) Study, Toronto, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • C reactive protein

  • Hepatocyte growth factor receptor

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved